使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
As a reminder, this call is being recorded. Please proceed.
提醒您,本次電話會議正在錄音。請繼續。
Gretchen Hommrich - Director of IR
Gretchen Hommrich - Director of IR
Good morning and welcome to Acadia's Third Quarter 2019 Conference Call. To the extent any non-GAAP financial measure is discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under the Investors link.
早安,歡迎參加 Acadia 2019 年第三季電話會議。若今日電話會議中討論任何非 GAAP 財務衡量指標,您亦可在我們網站的投資人連結下,查看昨日新聞稿,以取得該指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。
This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2019 and beyond. For this purpose, any statements made during this call that are not statements of historical fact may be deemed to be forward-looking statements.
本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義的前瞻性陳述,其中包括但不限於關於 Acadia 對 2019 年及其後預期的季度與年度財務表現之陳述。就此而言,本次電話會議中任何非歷史事實的陳述,均可能被視為前瞻性陳述。
Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the company's third quarter news release. And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The company undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise.
在不限制前述內容的情況下,「相信」、「預期」、「計畫」、「期望」及類似用語旨在識別前瞻性陳述。特此提醒您,這些陳述可能受到多項重要因素影響(其中包括但不限於)Acadia 向美國證券交易委員會提交的文件以及公司第三季新聞稿中所載之因素。因此,實際營運與結果可能與前瞻性陳述中討論的結果存在重大差異。公司不承擔公開更新任何前瞻性陳述之義務,不論係因新資訊、未來事件或其他原因。
At this time, for opening remarks, I would like to turn the conference call over to Chief Executive Officer, Debbie Osteen.
此刻,為了開場致詞,我想將電話會議交給執行長 Debbie Osteen。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Good morning, and thank you for being with us today for our third quarter conference call. I'm here today with Chief Financial Officer, David Duckworth, and other members of our executive management team. David and I are pleased to provide some remarks about the third quarter. We will then open the line for your questions.
早安,感謝各位今天參加我們的第三季電話會議。今天與我一同出席的有財務長 David Duckworth 以及我們執行管理團隊的其他成員。David 和我很高興就第三季提供一些說明。之後我們將開放提問。
For the third quarter, U.S. same facility revenue increased 4.9% with a 2.8% increase in patient days and a 2% increase in revenue per patient day compared with the prior year period. U.S. same facility EBITDA margin was 25.9% compared with 27.3% for the third quarter of 2018.
第三季,美國同一機構營收較去年同期成長 4.9%,其中病人日數增加 2.8%,每病人日營收增加 2%。美國同一機構 EBITDA 利潤率為 25.9%,相較於 2018 年第三季的 27.3%。
During the third quarter, we faced certain operating issues at a handful of our U.S. facilities. While we have historically had facilities that outperform and underperform against expectations in any given year, we believe the impact at these specific facilities has been unique due to the size of the facilities in terms of their revenue and earnings contribution to the company. There is not a systemic issue that has affected our business, and we continue to be confident in the long-term outlook for our company.
第三季期間,我們在少數幾家美國機構面臨某些營運問題。雖然歷來在任何一年中,我們都會有機構表現優於或低於預期,但我們認為這些特定機構的影響具有特殊性,原因在於其規模(就其對公司營收與獲利的貢獻而言)較大。並不存在影響我們業務的系統性問題,我們對公司長期展望仍然充滿信心。
Adjusting our same facility stats for these facilities: revenue growth is 7.1%, patient day growth is 4.4%, revenue per patient day growth is 2.6% and EBITDA margins would be flat as compared to the prior period. In the third quarter, we also had a few specialty facilities impacted by Hurricane Dorian. Patient volumes were affected in the month of September and some specialty patients were reluctant to travel to North Carolina and Florida for treatment due to the adverse weather. Combining the impact from the weather and the issues at the specific facilities, we estimate that the impact on EBITDA was approximately $9 million for the third quarter.
若將同一機構統計數據就這些機構進行調整:營收成長為 7.1%,病人日數成長為 4.4%,每病人日營收成長為 2.6%,而 EBITDA 利潤率相較前期將持平。第三季我們也有少數專科機構受到颶風多利安影響。9 月份病人量受到影響,且部分專科病人因惡劣天候而不願前往北卡羅來納州與佛羅里達州接受治療。綜合天候影響與特定機構問題,我們估計第三季對 EBITDA 的影響約為 900 萬美元。
We are very focused on executing our action plans to respond to these issues and have started to see progress from our efforts. However, as the exact timing for improvement and expected ramp-up of the census is uncertain, we have adjusted our full year guidance accordingly.
我們非常專注於執行行動計畫以回應這些問題,並已開始看到努力帶來的進展。然而,由於改善的確切時點與住院人數(census)預期回升的進度仍不確定,我們已相應調整全年財測指引。
In October, we had 3 facilities that were evacuated because of the wildfires in California, and several other facilities saw an impact to admissions and census. During the wildfires, we transferred our patients to other facilities, and as a result, our fourth quarter results will be impacted, and we have adjusted our guidance accordingly. Our staff had done an extraordinary job of keeping our patients safe in this very difficult time, and we commend them for their efforts.
10 月,我們有 3 家機構因加州野火而撤離,另有數家機構的收治入院與住院人數亦受到影響。野火期間,我們將病人轉送至其他機構,因此第四季業績將受到影響,我們也已相應調整指引。在這段非常艱難的期間,我們的員工在確保病人安全方面表現卓越,我們對他們的努力致上敬意。
During the third quarter, we added 82 beds, increasing our size and geographic scale and further enhancing our position as a leading provider of behavioral health care services. Through the first 9 months of the year, we have added 414 beds and we expect to reach approximately 650 bed additions for the year.
第三季我們新增 82 張病床,擴大規模與地理覆蓋,並進一步強化我們作為行為健康照護服務領先供應商的地位。今年前 9 個月,我們已新增 414 張病床,並預期全年新增病床數約可達 650 張。
Throughout the quarter, we have continued to make progress around achieving the savings generated to the operational initiatives outlined in the strategic review update in May. We continue to expect the $20 million to $25 million of savings by year-end 2020. As detailed in the May update, most of the savings will be in procurement which will impact supplies and other operating expenses.
整個季度期間,我們持續在實現 5 月策略檢討更新中所列營運倡議所帶來的節省方面取得進展。我們仍預期至 2020 年底可達成 2,000 萬至 2,500 萬美元的節省。如 5 月更新所述,多數節省將來自採購,並將影響耗材與其他營運費用。
We recently completed a rebid of our GPO, and as a result, we'll be making a change in the first part of 2020. We have also added resources at the corporate level to oversee our projects and ensure achievement of our goal. We believe these steps will facilitate the savings outlined in the review. We will continue to provide updates as we realize the benefits of these initiatives.
我們近期完成了對 GPO 的重新招標,因此將在 2020 年初進行更換。我們也在公司層級增補資源以監督專案並確保達成目標。我們相信這些步驟將促成檢討中所列的節省。隨著我們逐步實現這些倡議的效益,我們將持續提供更新。
Before turning to the U.K., I'd like to reemphasize our commitment to our partnership strategy. We have a strong track record of partnering with health systems and hospitals across the country. We have 5 joint ventures operating and 3 currently under development with a robust pipeline of over 20 projects in different stages of development.
在談到英國之前,我想再次強調我們對合作夥伴策略的承諾。我們在全國與健康系統及醫院合作方面擁有強勁的實績。我們目前有 5 個合資企業在營運,另有 3 個正在開發中,並且有超過 20 個處於不同開發階段的強勁專案管線。
The market remains strong and the value proposition to our provider partners is very compelling. As part of our strategic plan, we are targeting 2 JVs and 1 wholly owned de novo build per year.
市場仍然強勁,我們對提供者合作夥伴的價值主張極具吸引力。作為我們策略計畫的一部分,我們的目標是每年推進 2 個合資案(JV)以及 1 個全資自建的全新開發案(de novo)。
We are excited that we have broken ground on our new JV hospital with Saint Thomas Health, a part of the Ascension Health system and the largest not-for-profit health system in the U.S. The partnership includes the establishment of a new 76-bed psychiatric inpatient hospital in Nashville, encompassing 40 adult beds and 36 geriatric beds.
我們很高興已為與 Saint Thomas Health 的新合資醫院動工;Saint Thomas Health 隸屬於 Ascension Health 醫療體系,亦為美國最大的非營利健康系統。該合作包含在納許維爾設立一所新的 76 床精神科住院醫院,其中包括 40 張成人病床與 36 張老年病床。
With respect to the U.K. operations, we were pleased to see continued stabilization in our operating metrics. Same facility revenue was up 4%, consisting of a 5.1% increase in revenue per day, driven by a 2.7% rate increase from the NHS and local payers and higher reimbursement related to an increase in the acuity of our patients. The increase in revenue per patient day was partially offset by a 1.1% decrease in patient days, which is related to our retooling efforts outlined on our second quarter call. If these beds were online, and when they do come back online, we believe this will contribute approximately 2% to our patient day growth, which would imply approximately 6% revenue growth in the U.K. Same facility EBITDA margin was 16.7%, consistent with our expectations. Total facility EBITDA margin increased over the prior year by 20 basis points to 15.2%.
就英國營運而言,我們很高興看到營運指標持續趨於穩定。同一機構營收成長 4%,其中每病人日營收增加 5.1%,主要受 NHS 與地方付款方 2.7% 的費率調升,以及因病人病情嚴重度(acuity)提高而帶來的較高給付所驅動。每病人日營收的增加,部分被病人日數下降 1.1% 所抵銷,這與我們在第二季電話會議中提到的重新調整(retooling)工作有關。若這些病床已上線,以及當它們重新上線時,我們相信將為病人日數成長貢獻約 2%,這意味著英國營收成長約 6%。同一機構 EBITDA 利潤率為 16.7%,符合我們的預期。總機構 EBITDA 利潤率較去年提高 20 個基點至 15.2%。
We were pleased to see an improvement in the third quarter labor costs as compared to the same period in the prior year. Agency labor as a percentage of total labor cost improved 60 basis points year-over-year to 13.4% for the third quarter of 2019 from 14% in the third quarter of 2018. Total labor cost as a percentage of total revenue improved 70 basis points year-over-year to 67.9% for the third quarter of 2019 from almost 69% in the third quarter of 2018.
我們很高興看到第三季的人力成本較去年同期有所改善。2019 年第三季,派遣人力占總人力成本的比例較去年同期改善 60 個基點,從 2018 年第三季的 14% 降至 13.4%。2019 年第三季,總人力成本占總營收的比例較去年同期改善 70 個基點,從 2018 年第三季接近 69% 降至 67.9%。
Operationally, the U.K. business continues to demonstrate stability. The team in the U.K. remains focused on operating the business as our sales process continues. We continue to work on reopening the beds offline for retooling, which involves identifying a facility where the patient can be transferred to, retooling the unit to the new service line and reopening the ward with qualified staff for the new service. We believe that there is a real long-term benefit from retooling that will add value to our operations and this has been demonstrated from our analysis of past retooling across the portfolio.
在營運面上,英國業務持續展現穩定性。隨著我們的銷售流程持續推進,英國團隊仍專注於業務營運。我們持續推動將因改造而暫停使用的床位重新開放,這包括:找出可將病患轉送至的機構、將病房單位改造為新的服務線,並以符合新服務需求的合格人員重新開放病房。我們相信改造能帶來實質的長期效益、為營運增值,而我們對過往在整體投資組合中進行改造的分析也證明了這一點。
The demand for our services in the U.K. has been consistent. Priory continues to receive referrals for the highest levels of acuity across all divisions and continuously reviews our services to ensure this market need is safely met. We believe we are well positioned to take advantage of future demands across our service lines. With the beds that we've retooled, we believe this will help with future growth. We will continue to work with the NHS and other referral sources to identify areas in which we can help meet their demands.
英國市場對我們服務的需求一直很穩定。Priory 持續在各事業部收到最高急性程度(acuity)的轉介,並持續檢視我們的服務,以確保能安全地滿足此市場需求。我們相信我們已具備良好定位,可把握未來各服務線的需求。就我們已完成改造的床位而言,我們相信這將有助於未來成長。我們將持續與 NHS 及其他轉介來源合作,找出我們可以協助滿足其需求的領域。
Finally, before we discuss our financial results in greater detail, I'd like to address our ongoing exploration of a potential sale of our U.K. business. As previously announced, the Board has engaged a financial adviser to run a process to explore the sale of the entirety of the U.K. business. We have engaged in preliminary conversations with a number of interested parties and have completed the necessary front-end preparatory steps consistent with market practice for U.K. transactions of this nature. We are continuing discussions with prospective parties and after consulting with our advisers, and in light of the upcoming December elections in the U.K., we expect to solicit initial bids for the U.K. business early next year. We believe this time line provides the best path forward for optimizing the certainty of the sale process and maximizing value for our shareholders in a thoughtful and deliberate manner.
最後,在我們更深入討論財務結果之前,我想先說明我們持續探索出售英國業務的進展。如先前所公告,董事會已聘請財務顧問主導流程,以探索出售整體英國業務。我們已與多家有興趣的潛在買方進行初步對話,並已完成此類英國交易依市場慣例所需的前端準備步驟。我們正持續與潛在方討論;在與顧問諮詢後,並考量英國即將於 12 月舉行選舉,我們預期將於明年初就英國業務徵求初步出價。我們相信此時間表能為優化出售流程的確定性並以審慎、周延的方式為股東極大化價值,提供最佳前進路徑。
Now I will turn the call over to David Duckworth to discuss our financial results and guidance in more detail.
接下來我將把電話會議交給 David Duckworth,請他更詳細說明我們的財務結果與財測指引。
David M. Duckworth - CFO
David M. Duckworth - CFO
Thanks, Debbie, and good morning. Revenue for the third quarter was $777.3 million compared with $760.9 million for the third quarter of 2018. Our consolidated revenue growth of 2.1% was affected by the foreign currency exchange rate and revenue generated by closed facilities in the prior year. The exchange rate had a $15 million or a 2% impact on revenue and revenue growth and the closed facilities had a $13 million or a 1.7% impact on revenue and revenue growth. Consolidated revenue growth adjusted for these 2 factors was 5.8%.
謝謝 Debbie,大家早安。第三季營收為 7.773 億美元,相較於 2018 年第三季的 7.609 億美元。我們合併營收成長 2.1% 受到外匯匯率以及前一年已關閉設施所貢獻營收的影響。匯率對營收與營收成長的影響為 1,500 萬美元(約 2%),而已關閉設施對營收與營收成長的影響為 1,300 萬美元(約 1.7%)。剔除這兩項因素後,合併營收成長為 5.8%。
The company's consolidated adjusted EBITDA for the third quarter of 2019 was $146.6 million or 18.9% of revenue. As it relates to third quarter adjusted EBITDA, as Debbie mentioned, our results were impacted by $9 million related to the specific U.S. facilities and the hurricane. Additionally, the EBITDA impact of the lower exchange rate, which has rebounded to approximately 1.29 today but averaged 1.233 for the third quarter, was approximately $2.2 million.
公司 2019 年第三季合併調整後 EBITDA 為 1.466 億美元,約占營收 18.9%。就第三季調整後 EBITDA 而言,如 Debbie 所提,我們的結果受到與特定美國設施及颶風相關的 900 萬美元影響。此外,較低匯率對 EBITDA 的影響(目前已回升至約 1.29,但第三季平均為 1.233)約為 220 萬美元。
Net income attributable to Acadia stockholders was $42.6 million or $0.48 per diluted share for the third quarter of 2019 compared with net income of $46.2 million or $0.53 per diluted share for the third quarter of 2018. Adjusted income attributable to Acadia stockholders for the third quarter of 2019 was $46 million or $0.52 per diluted share excluding transaction-related expenses of $5.8 million and an income tax effect of adjustments to income of $2.4 million based on a tax rate of 16.7%.
2019 年第三季歸屬於 Acadia 股東的淨利為 4,260 萬美元,稀釋後每股盈餘 0.48 美元;相較之下,2018 年第三季淨利為 4,620 萬美元,稀釋後每股盈餘 0.53 美元。2019 年第三季歸屬於 Acadia 股東的調整後淨利為 4,600 萬美元,稀釋後每股盈餘 0.52 美元;此數字排除交易相關費用 580 萬美元,並以 16.7% 稅率計入對所得調整的所得稅影響 240 萬美元。
Turning to our financial guidance. As noted in our press release, we have revised our guidance for the full year 2019 as follows: revenue in a range of $3.1 billion to $3.125 billion, adjusted EBITDA in a range of $584 million to $589 million and adjusted earnings per diluted share in a range of $2 to $2.05.
接著談我們的財測指引。如我們新聞稿所述,我們已將 2019 年全年指引修正如下:營收介於 31 億至 31.25 億美元;調整後 EBITDA 介於 5.84 億至 5.89 億美元;稀釋後每股調整後盈餘介於 2.00 至 2.05 美元。
Our revised EBITDA guidance reflects the third quarter results as well as the following assumptions related to the fourth quarter: a continued impact from the issues related to the specifically identified U.S. facilities and temporary facility closures related to the wildfires in California; secondly, an exchange rate assumption of approximately 1.28 based on actual exchange rates for the month of October, plus an estimate of 1.29 for the last 2 months of the year; and a tax rate of approximately 17%.
我們修正後的 EBITDA 指引反映第三季結果,以及與第四季相關的以下假設:第一,先前所特別指出的美國設施相關問題仍將持續影響,且加州野火導致的設施暫時關閉亦將帶來影響;第二,匯率假設約為 1.28(基於 10 月實際匯率),並估計今年最後兩個月為 1.29;以及稅率約為 17%。
We would like to briefly discuss the overall trends of the business and expectations for 2020. As Debbie mentioned earlier, we believe the issues at these facilities are temporary, and we are working to address the challenges with action plans. We do not believe there's a systemic issue or challenge that had an impact across all of our facilities or within one service line or geographic region.
我們想簡要討論業務的整體趨勢以及對 2020 年的預期。如 Debbie 先前提到,我們認為這些設施的問題屬暫時性,我們正透過行動計畫來處理相關挑戰。我們不認為存在會影響我們所有設施、或在單一服務線、或單一地理區域造成影響的系統性問題或挑戰。
We continue to believe that the demand for mental health and substance use services is strong. We firmly believe that by executing on our action plans and our operational improvement initiatives, we will see high single-digit revenue growth and EBITDA margin improvement in 2020. We look forward to discussing our targets for next year when we provide our 2020 guidance on the fourth quarter call but wanted to provide this additional context today around our expectations. We remain very excited about the potential of our platform and confident about the future.
我們仍相信心理健康與物質使用(成癮)服務的需求強勁。我們堅信,透過落實行動計畫與營運改善措施,我們將在 2020 年看到高個位數的營收成長,以及 EBITDA 利潤率的改善。我們期待在第四季電話會議提供 2020 年指引時,進一步討論我們明年的目標,但今天希望就我們的預期提供更多背景。我們對平台的潛力仍感到非常振奮,並對未來充滿信心。
This concludes our prepared remarks this morning. I'll now ask Paul to open the floor for your questions.
以上為我們今天上午的準備發言。接下來我將請 Paul 開放提問。
Operator
Operator
(Operator Instructions) I will now take our first question from A.J. Rice from Crédit Suisse.
(接線員指示) 我現在將接聽第一個問題,來自 Crédit Suisse 的 A.J. Rice。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
So just first of all, to drill down a little bit more on the troubled facilities and how long it might take to get those back on track, so $9 million in Q3. Obviously, with the revised guidance, you're looking at more in the fourth quarter. So some of that must have happened toward the end of the quarter as you sort of alluded to. You've also got the wildfires and the hurricane. Any way to parse out how much of the fourth quarter adjustment relates specifically to those 5 facilities? And then when you describe whether it's the natural disasters or these facilities, is -- are you going to -- do you think at this early point, you'll probably have some spillover into the first half of 2020? Or will you have it, you think, back on track by then?
首先,我想更深入了解一下這些出狀況的設施,以及大概需要多久才能讓它們回到正軌;第三季影響是 900 萬美元。顯然,依照修正後的指引,你們預期第四季影響會更大。所以其中一部分應該是發生在季末,正如你們稍早所暗示的。你們也遇到野火和颶風。有沒有辦法拆解一下,第四季調整中有多少是特別與那 5 家設施相關?另外,當你們描述不論是天然災害或這些設施的影響時——以目前這個時間點來看——你們認為可能會延續到 2020 年上半年嗎?還是你們認為到那時就能回到正軌?
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. A.J., we did mention the third quarter impact at these specific facilities of around $8 million, $9 million if you include the hurricane. And we do believe since the timing of those issues, many of which occurred in the middle or later part of the third quarter, that there is an ongoing impact in the fourth quarter. Additionally, we have had bed additions at several of these facilities that we previously expected would contribute to our earnings in the fourth quarter. We now see a delay of that, continue to be optimistic about those bed additions ramping but see a delay in that into 2020.
是的。A.J.,我們確實提到第三季在這些特定設施的影響約為 800 萬至 900 萬美元,若將颶風因素納入則約為 900 萬美元。而且我們確實認為,鑑於這些問題的發生時點(其中許多發生在第三季中段或後段),第四季仍會有持續性的影響。此外,我們在其中幾家設施新增了床位,先前預期這些新增床位會在第四季對我們的獲利有所貢獻。我們現在看到這部分有所延遲;我們仍對這些新增床位的爬坡(ramp)保持樂觀,但看到延遲延伸到 2020 年。
So the fourth quarter does reflect a revision that not only reflects just the timing of these issues but also the bed addition contribution that we expected that we now think will be delayed to next year. In terms of just the size of it, it is around $15 million. And again, that just reflects the timing of it. We do believe that many of the issues can be addressed very quickly and are very positive about the action plans that we have in place and believe that the issues can be addressed in the near term. And I do think there will be some ramp back up to the normal level of operations from these facilities and we expect that to occur early in 2020 following the issues being addressed over the next several months.
因此,第四季確實反映了一項修正,不僅反映這些問題的時點影響,也反映我們原先預期的新增床位貢獻,而我們現在認為將延後到明年。就規模而言,約為 1,500 萬美元。而且再次強調,這只是反映時點的影響。我們確實相信許多問題可以很快解決,並且對我們已制定的行動計畫非常有信心,認為這些問題可在短期內處理完成。我也確實認為,這些設施的營運將會逐步回升至正常水準;我們預期在未來幾個月內把問題處理好之後,於 2020 年初發生。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
I guess just one other way to think about it, it seems a little long that you'd have these 5 different facilities, all have -- significant facilities have issues at roughly the same time. Was there an initiative that the company had undertaken? Was there something happening on the policy front? Any -- if we step back and think about the fact that you had all this happen in one time period, is there any rhyme or reason to it from your perspective?
我想換個角度來看,似乎有點久:你們有 5 家不同的設施,而且都是——重要的設施——在差不多同一時間出現問題。公司是否曾推動某項倡議(initiative)?是否有政策面發生了什麼事?如果我們退一步看,這些事情在同一期間發生,從你們的角度來看,有沒有任何脈絡或原因?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
A.J., There really isn't. These issues are very unique to the facilities that have had the impact. There's not really even a common service line here. It's not a common state. We had -- our initiative has been to focus on our growth and our performance improvement, but nothing that we had done here or frankly, throughout the company has caused these issues. I think they're very unique. They're very individualized, and we believe that they don't reflect the majority of our business, which is why we've really called them out to focus on but they are not reflective of the strength of the company, and there's no trend from a macro perspective that we see causing these issues. They're very individualized and unique.
A.J.,其實沒有。這些問題都非常獨特,僅限於受到影響的那些設施。這裡甚至沒有共同的服務線。也不是同一個州。我們的——我們的倡議一直是聚焦於成長與績效改善,但我們在這裡所做的事情,或坦白說,公司整體所做的任何事情,都沒有造成這些問題。我認為它們非常獨特。它們非常個別化;我們相信它們並不代表我們大多數的業務,這也是為什麼我們特別點出來讓大家聚焦,但它們並不反映公司的實力;而且從宏觀角度來看,我們也沒有看到任何趨勢導致這些問題。它們非常個別且獨特。
Operator
Operator
We will now take our next question from Brian Tanquilut from Jefferies.
接下來我們將接聽 Jefferies 的 Brian Tanquilut 的提問。
Brian Gil Tanquilut - Senior Equity/Stock Analyst
Brian Gil Tanquilut - Senior Equity/Stock Analyst
I guess my first question, Deb -- Debbie, to follow-up on that point that you just made. So if we isolate and take out the 5 facilities, what would the business have looked like in the U.S.? Number one. And then I guess the second part of that is what are the steps that you've taken to address the issues in terms of time line? Is it a 1-quarter issue, you think? Or is this something that would take 6 months, 9 months before we see the improvements?
我想我的第一個問題,Deb——Debbie,延續你剛才提到的那點。如果我們把這 5 家設施單獨隔離並剔除,美國業務會呈現什麼樣貌?這是第一點。然後第二部分是:就時程而言,你們採取了哪些步驟來解決這些問題?你認為這會是一個 1 季的問題嗎?還是需要 6 個月、9 個月,才會看到改善?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Well, I think if we back out those facilities, the third quarter -- the revenue growth for the third quarter would be 7.1%. If you look at patient day growth, it's 4.4% versus the 2.8%. And then revenue per patient day, we would see an increase of 2.6%. Our EBITDA margin would be flat, and I think that, that reflects really the majority of the facilities across all of our service lines. I do think that there are action plans that are in place. The team is very focused on getting these specific unique issues resolved, and I believe they feel that these issues will be resolved over the next quarter. They have very good plans. They are working very hard to make sure they're implemented properly and that we end up starting 2020 with this behind us.
嗯,我認為如果把那些設施剔除,第三季——第三季的營收成長率會是 7.1%。如果看病患日(patient day)成長,會是 4.4%,相較於 2.8%。然後每病患日營收(revenue per patient day)會增加 2.6%。我們的 EBITDA 利潤率會持平;我認為這確實反映了我們在所有服務線中絕大多數設施的表現。我確實認為我們已經有行動計畫在執行。團隊非常專注於解決這些特定且獨特的問題,我相信他們認為這些問題會在下一個季度內解決。他們有非常好的計畫。他們非常努力,確保計畫能正確落實,並讓我們在 2020 年開始時把這些問題拋在身後。
Brian Gil Tanquilut - Senior Equity/Stock Analyst
Brian Gil Tanquilut - Senior Equity/Stock Analyst
So I guess, Debbie, to follow up on that, where do you sit today? Has your view on the 2020 earnings power of the company changed versus where you were, say, at the end of the second quarter?
那我想,Debbie,延續這點,你目前的看法如何?相較於例如第二季末,你對公司在 2020 年的獲利能力(earnings power)的看法有改變嗎?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Yes. My view has not changed. I see the strength of the company. I see the opportunity for Acadia. I'm disappointed for this temporary disruption because it doesn't reflect the overall strength of Acadia. I think we have enormous potential across all of our service lines. And I think that we do have an opportunity to improve, which we're doing through these performance initiatives, and we want to strengthen our balance sheet. But I have not changed my view at all, and I believe that 2020 can be a very strong year for the company, and I think that we will get these issues resolved. We're working very hard to do so but I feel very positive about our future.
有。我的看法沒有改變。我看到公司的實力。我看到 Acadia 的機會。我對這次暫時性的干擾感到失望,因為它並不反映 Acadia 的整體實力。我認為我們在所有服務線上都有巨大的潛力。而且我認為我們確實有改善的空間,我們正透過這些績效倡議來推動,同時我們也希望強化資產負債表。但我的看法完全沒有改變;我相信 2020 年對公司而言可以是非常強勁的一年,我也認為我們會把這些問題解決。我們正非常努力地去做,但我對我們的未來感到非常正面。
Operator
Operator
Our next question comes from Kevin Fischbeck from Bank of America.
接下來的問題來自美國銀行(Bank of America)的 Kevin Fischbeck。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
This is Joanna Gajuk filling in for Kevin today. So just to follow up on this comment, and I have another one. So in terms of the U.S. business, because I know one of your peers experienced some pressures in the -- specifically in the substance abuse business in the U.S. So is any of these facilities somewhat impacted by that? And on -- also, if not, then are you seeing any increased competition in that area?
我是 Joanna Gajuk,今天代替 Kevin。我想延續剛才這個評論再追問一下,另外我還有一個問題。就美國業務而言,因為我知道你們的一家同業在——特別是在美國的物質濫用(substance abuse)業務——面臨一些壓力。那你們提到的這些設施是否有任何一部分受到那方面影響?另外——如果沒有的話,那你們在該領域是否看到競爭加劇?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
No. We really have not experienced any of the industry trends that have been mentioned by our peer. We have very solid performance in our specialty service line. It's actually a very -- it's one of our leading platforms. And I think that with the opioid epidemic and the ongoing demand, I think we have been very pleased with the performance. It's not impacting the facilities that we've mentioned. We also have a very unique sales and marketing platform which works very well. And so I think that as we look across the -- that service line, in particular, we don't see the issues that I think have been mentioned. Our out-of-network is less than 5% of our revenue in patient days in the substance use service line. So we've already transitioned many of our contracts and our payer relationships to that. So that puts us in a very good place because I think as consumers do start to want to be more in network with their coverage, we are going to be able to service them throughout the portfolio.
沒有。我們確實沒有經歷任何同業所提到的產業趨勢。我們在專科服務線(specialty service line)的表現非常穩健。事實上那是一個非常——它是我們的領先平台之一。而且我認為,隨著類鴉片(opioid)疫情以及持續的需求,我們對其表現一直非常滿意。它並未影響我們提到的那些設施。我們也有一個非常獨特的銷售與行銷平台,運作得非常好。因此我認為,當我們檢視——尤其是該服務線——我們並沒有看到我認為同業所提到的那些問題。在物質使用(substance use)服務線中,我們的網外(out-of-network)在病患日口徑的營收占比低於 5%。因此我們已經把許多合約與支付方(payer)關係轉換到那樣的狀態。這讓我們處於非常有利的位置,因為我認為當消費者開始希望其保險給付更偏向網內(in network)時,我們將能在整個產品組合中為他們提供服務。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
Great. That's very helpful. And if I can switch the topics to the U.K. business, which seems like it's continuing to stabilize there, so any change in your outlook, I guess, for next year in terms of labor cost? I appreciate the commentary around these retooling efforts and the benefits of coming with it. So I guess, on that front also, do you expect an incremental pricing increases when you have more of these? Or it just comes with the higher acuity mix?
太好了。這非常有幫助。如果我可以把話題轉到英國業務,看起來那邊仍在持續趨於穩定,那麼我想請問,對於明年的人力成本,你們的展望有任何改變嗎?我也很感謝你們對這些重新調整(retooling)措施及其帶來效益的評論。所以我想在這方面也請教一下,當你們推動更多這類措施時,是否預期會有額外的價格上調?還是說這只是因為病患組合的病情嚴重度(acuity mix)提高所帶來的結果?
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. Joanna, this is David. I think our outlook for the U.K. continues to be positive. We expect that the labor costs that we have seen a lot of stability around in the last several quarters that, that will continue. The revenue per patient day growth, as Debbie mentioned earlier, reflects 2.7% pricing increases as well as the higher level of acuity that we're seeing in many of our patients. And the margin, we -- the margin continues to be solid. 15.2% for the quarter is within our range, and we think we're positioned well for volume growth and bringing beds back online next year, which will get us into a revenue growth in the mid-single-digit range. So we do see not only stability and improved performance this quarter but have a positive outlook for 2020 in the U.K.
是的。Joanna,我是 David。我認為我們對英國的展望仍然正向。我們預期,過去幾個季度我們看到相當穩定的人力成本,這種穩定性將會延續。如 Debbie 先前提到的,每病患日收入(revenue per patient day)的成長反映了 2.7% 的價格調漲,以及我們在許多病患身上看到的更高病情嚴重度。至於利潤率,我們——利潤率仍然穩健。本季 15.2% 落在我們的區間內,我們也認為我們已為明年的量能成長與床位重新啟用做好準備,這將使我們的營收成長落在中個位數百分比(mid-single-digit)的區間。因此,我們不僅看到本季的穩定與改善表現,也對 2020 年英國業務抱持正向展望。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
Great. That's helpful. And if I may just squeeze a last one since I have you here. In terms of the refinancing that you mentioned that took place in August and you paid down some debt. So I guess, you've seen some of benefit in third quarter. Am I right in estimating that the annual sort of benefit of these action is about $8 million, $9 million with action to interest expense. Is that in the ballpark? n
很好。這很有幫助。如果可以的話,趁你在線上我再擠最後一個問題。關於你們提到 8 月完成的再融資,以及你們也償還了一些債務。所以我想,你們在第三季已經看到一些效益。我估算這些動作對利息費用的年度效益大約是 800 萬到 900 萬美元。這個數字大致合理嗎?n
David M. Duckworth - CFO
David M. Duckworth - CFO
We did complete that transaction in mid-August. So we saw about 0.5 quarter of an impact from that. There is interest savings related to that transaction but it is more like $4 million to $5 million annually. So we saw the 1.5 months' worth of that savings during the quarter, but the annual benefit from that is $4 million to $5 million.
我們確實在 8 月中旬完成了那筆交易。因此,我們大約看到 0.5 個季度的影響。這筆交易確實帶來利息節省,但年度金額更接近 400 萬到 500 萬美元。所以本季我們看到約 1.5 個月的節省,但年度效益是 400 萬到 500 萬美元。
Joanna Sylvia Gajuk - VP
Joanna Sylvia Gajuk - VP
Right. Because there's also some debt you paid down, wasn't it? So that's all inclusive, the $4 million to $5 million annually, that's the refinancing and also the lower debt?
了解。因為你們也償還了一些債務,不是嗎?所以 400 萬到 500 萬美元的年度金額是全包的,包含再融資以及債務降低帶來的效益?
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. That's correct. We did pay down the $60 million that was outstanding on our revolver. We now have full availability of that revolver, and we paid the $60 million down on the revolver, Joanna, and then we have about $40 million of cash that we put on our balance sheet following that transaction.
是的。沒錯。我們確實償還了循環信貸(revolver)上尚未償還的 6,000 萬美元。我們現在對該循環信貸有完整可用額度(full availability),而且我們把循環信貸的 6,000 萬美元還清了,Joanna;
Operator
Operator
Our next question comes from Matthew Gillmor from Baird.
我們的下一個問題來自 Baird 的 Matthew Gillmor。
Matthew Dale Gillmor - Senior Research Analyst
Matthew Dale Gillmor - Senior Research Analyst
I was hoping to get a little more detail on the nature of the operational issues that you called out. It sounds like they're unique to each facility. So I appreciate if you don't want to go through each one, but if you could maybe just provide 1 or 2 examples that impacted some of the larger facilities just to help us understand.
我希望能更詳細了解你們提到的營運問題的性質。聽起來這些問題在各個機構(facility)都不太一樣。所以我理解你們可能不想逐一說明,但如果可以的話,能否提供 1 到 2 個例子,說明哪些因素影響了一些較大型的機構,幫助我們理解?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Sure. I'd be happy to, Matt. I mean, one of our large specialty facilities made a change in their services in August and early into September. We -- they had been treating specialty patients but also mental health patients. And we looked at and heard feedback from our referral sources that mixing those 2 patient types of more acute mental health with specialty with the layout of the facility was actually, I think, causing our referral sources to be hesitant to send the specialty patients to us. They don't really mix well when you take the layout of this campus. I think we've done this successfully in other locations around the country where we do co-occurring and we do treat both. But in this situation, because of the layout, it just did not work well. We made the change and I think that we brought in some outside resources to actually help us with the marketing because as we change and focus back solely on the specialty and substance use business, it is a ramp. While we were changing the service and we stopped taking the mental health patients, we were reluctant to address the cost structure because we wanted to make sure we were ready to make this change and to start accepting patients. I think that, that impacted the cost, again, back to our margin impact. But I do believe the action plans that are in place are working. We are starting to ramp back up. And we see that continuing. I think we've had a lot of positive feedback from referrals that are very pleased that we've made this change, and it's a long-term core competency for this facility in the specialty area. So we feel that we can recover very quickly from deciding to stop taking these acute mental health patients. So that's one example.
當然。我很樂意,Matt。我們其中一家大型專科機構在 8 月以及 9 月初對其服務做了調整。我們——他們原本在治療專科病患,同時也收治精神健康病患。我們檢視並聽取轉介來源(referral sources)的回饋後發現,在該機構的場地配置下,把較高急性度的精神健康病患與專科病患混在一起,實際上讓轉介來源對把專科病患送來我們這裡有所顧慮。就這個園區的配置而言,兩者確實不太能良好混合。我認為我們在全國其他地點曾成功推動共病(co-occurring)模式並同時治療兩者。但在這個案例中,由於場地配置,效果並不好。因此我們做了調整,並引入一些外部資源協助行銷;因為當我們改變方向、重新聚焦於專科與物質使用(substance use)業務時,需要一段爬坡期(ramp)。在我們調整服務並停止收治精神健康病患的同時,我們對成本結構的調整也較為保守,因為我們想確保已準備好完成這項改變並開始接收病患。我認為這影響了成本,也再次回到我們對利潤率的影響。但我確信目前的行動方案正在發揮作用。我們正開始重新爬升。而且我們看到這個趨勢會持續。我想我們從轉介端收到很多正面回饋,他們很高興我們做了這項改變;而且在專科領域,這是該機構長期的核心能力。因此,我們認為在決定停止收治這些高急性度精神健康病患之後,我們可以很快恢復。這是一個例子。
I'll give another one. We have a state where we have operated a campus as one license, and so we staffed in that way. We had a licensure interpretation that has directed us to staff by our buildings, which requires 5 licenses. There is a waiver for the license which we've applied for. But as we had patients at our facility there, it had a pretty big impact on cost because as we have had to staff up per building, which is a big increase in our end, we actually had to bring an agency to actually meet those needs. But we're hoping to hear very soon about our new integrated license, and we don't see any reason at this point that we would not get that. But that's another example of really a unique situation that happened in one of the facilities that had a pretty substantial impact on their cost.
我再舉另一個例子。我們在某個州原本以一張執照(one license)來營運一個園區,因此我們也以那樣的方式配置人力。但後來有一項對執照的解釋(licensure interpretation)要求我們必須按建築物來配置人力,這就需要 5 張執照。針對該執照要求有一個豁免(waiver),我們已提出申請。但在那段期間,因為我們的機構仍有病患,成本受到相當大的影響;由於必須按每棟建築增派人力(對我們而言是大幅增加),我們實際上還必須使用派遣人力(agency)來滿足需求。不過我們希望很快就能收到關於新的整合式執照(integrated license)的消息,目前看不出有任何理由我們拿不到。但這也是另一個只發生在單一機構、相當特殊的情況,對其成本造成了相當顯著的影響。
Matthew Dale Gillmor - Senior Research Analyst
Matthew Dale Gillmor - Senior Research Analyst
Got it. That's helpful in understanding. And then one clarification on your 2020 comments. So you talked about the high single-digit revenue growth and EBITDA margin improvement. I just wanted to confirm, that's against the current guide you've provided, that's not adding back the headwinds you're calling out. And then I think David did, but I just wanted to confirm that this also includes both the U.K. and the U.S.
了解。這有助於理解。另外,關於你們對 2020 年的評論,我想再釐清一下。你們提到高個位數的營收成長以及 EBITDA 利潤率改善。我想確認一下,這是相對於你們目前提供的指引(guide),並沒有把你們提到的逆風(headwinds)再加回去,對嗎?另外我想 David 有提到,但我也想確認,這也同時包含英國與美國兩個市場?
David M. Duckworth - CFO
David M. Duckworth - CFO
Well, Matt, I think we'll go into more detail, obviously, around our 2020 guidance in February as we report our fourth quarter results. And -- but we do believe, just with the turnaround at these specific facilities, combined with the operational improvement initiatives we have in place in the U.S. as well as just the bed addition contribution and the benefit that we expect from facility expansions, that's the commentary we've provided, is that we have a positive outlook for 2020. We will provide more detail as we report our fourth quarter results.
嗯,Matt,我想我們顯然會在2月公布第四季業績時,針對我們的2020年指引提供更詳細的說明。而且——但我們確實相信,隨著這些特定設施的改善,加上我們在美國推動的營運改善措施,以及新增床位的貢獻與我們預期來自設施擴建的效益,我們先前提供的評論是:我們對2020年持正向展望。我們會在公布第四季業績時提供更多細節。
Operator
Operator
We will now take our next question from Pito Chickering from Deutsche Bank.
接下來我們將接受德意志銀行(Deutsche Bank)Pito Chickering的提問。
Philip Chickering - Research Analyst
Philip Chickering - Research Analyst
Just a follow-up on Matt's, you guys did offer sort of this high single-digit EBITDA growth and you guys are in the process of -- you commented you're soliciting the sale of the U.K. in beginning of next year. So just to be super clear, because you gave that number, is that for the corporate average? So that would be -- imply a 6 33 EBITDA? Or is that solely against the U.S., which could infer something in the range of 5 70 in the U.S. for next year?
就Matt的問題再追問一下,你們確實提到大約高個位數的EBITDA成長,而且你們正在進行——你們也評論說,將在明年年初徵詢出售英國業務。所以為了非常清楚,既然你們給了那個數字,那是以公司整體平均來看嗎?也就是——意味著EBITDA為6 33?還是那僅針對美國,這可能推導出明年美國約在5 70的區間?
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. Pito, we will be more precise about that next year. I do think that when we talk about our expected growth, it is based on a normal year, and so we do expect that with the recovery from these items, we could see stronger growth in 2020, but again, we'll provide more detail about that in February.
是的。Pito,我們明年會把這點說得更精確。我確實認為,當我們談到預期成長時,是以正常年度為基礎,因此我們預期隨著這些事項的復原,2020年可能會看到更強的成長,但同樣地,我們會在2月提供更多細節。
Philip Chickering - Research Analyst
Philip Chickering - Research Analyst
Okay. Fair enough. Can you give us an update of how the beds ramping in the U.K. that you took offline? I think you mentioned in the last quarter, an additional 150 beds were taken offline for further retooling. Any updates on those? And also on the U.S. de novos that were slow to ramp in the first half of the year.
好的。可以。你能更新一下英國那批你們先前下線的床位回升(ramping)的情況嗎?我記得你們在上一季提到,另外有150張床位為了進一步改造而下線。那些有任何更新嗎?另外也想問美國上半年爬坡較慢的de novos(新設據點)。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Pito, we have seen in the U.K. some of those beds come back online, but we really didn't expect to see much in the third quarter. We do expect to see some additional beds come back on in the fourth quarter. Most of the retooled beds will be coming on in 2020, and I think that it's a process which I talked about earlier. We have patients that we have to move out and they have to go to a secure setting and then there is a retooling. So some of this can take up to 6 months. Some can be done much faster. But as we retool these beds, we then ramp back up with staff. So we expect that these beds will be back online by 2020 and it's my hope that they're in the earlier part of the year. I think management is trying to accelerate as much as possible. They work with the referral sources on placing these patients. So some of that depends on collaboration of where these patients are going, but I think that we feel good that when these beds do come back online, they have a very positive impact on the results for the U.K.
Pito,我們在英國已看到其中一些床位重新上線,但我們其實不預期第三季會看到太多。我們確實預期第四季會有一些額外床位回到線上。大多數改造後的床位會在2020年上線,我想這是一個我先前提過的流程。我們必須把病患移出,他們必須轉到安全的安置環境,然後才進行改造。因此其中一些可能需要長達6個月。有些則可以更快完成。但當我們改造這些床位後,我們也會隨之把人力配置逐步拉升。所以我們預期這些床位會在2020年前回到線上,我希望是在年初較早的時點。我認為管理團隊正盡可能加速。他們會與轉介來源合作來安置這些病患。因此其中一部分取決於病患去向的協作,但我認為我們很有信心,當這些床位重新上線時,將對英國的業績帶來非常正面的影響。
And with respect to the U.S., our de novos are coming along. I think that we're pleased to see after we were able to clear some of the license and certification issues that the market demand is there. They're coming along very nicely. They're well within what we projected. And both markets, I think, are going to be very strong for the company.
至於美國,我們的新設據點(de novos)進展順利。我想我們很高興看到,在我們解決了一些執照與認證問題之後,市場需求確實存在。它們進展得非常好。完全在我們的預測範圍之內。而且我認為這兩個市場都將對公司非常強勁。
Philip Chickering - Research Analyst
Philip Chickering - Research Analyst
Okay. And then my last question from a process perspective, Debbie, you mentioned earlier that you're investing within -- more on the corporate side. And there's been a couple of hiccups sort of 2Q and 3Q and sort of facilities having issues here and there. Can you sort of walk us through from a process perspective how you've changed sort of the corporate oversight team? And kind of how does it improve over the next 12 months?
好的。那我最後一個問題是從流程角度來看,Debbie,你先前提到你們正在加大——在公司層面投入更多。而且第二季、第三季似乎出現了一些小插曲,某些設施不時出現一些問題。你能否從流程角度帶我們了解一下,你們如何調整公司端的監督(oversight)團隊?以及在未來12個月會如何改善?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Sure. Well, we've done several things. We have had an outside group working with us to identify savings throughout the company. We have used some of their expertise with the GPO, but we need our own procurement person, and we have identified and hired that person who will oversee the process. We've also brought on an individual that will make sure that all of the parts of this work well. We're a big company but we have a lot of opportunity. So we want to make sure we're keeping track of that and staying on schedule. We have centralized our contracts for managed care. We have a database now. We have better visibility around contract timing, rates. We have a team in place to make sure that, that progress continues. We also have made some changes to our financial structure and reporting so that we can have greater visibility around our day-to-day cost management. And I think that the group and the team here is very strong. I think that it's been a group that had been here for several years. They're working well. But what we've tried to do is enhance what's already the strength here and to get visibility around what we can do to accelerate growth but also to manage the day-to-day costs and performance improvement initiatives.
當然。嗯,我們做了幾件事。我們請了一個外部團隊與我們合作,找出全公司各處的節省機會。我們運用他們在GPO方面的一些專業,但我們需要自己的採購人員,因此我們已經確認並聘用了該人選來負責監督流程。我們也引進了一位人員,確保這項工作的各個環節都能順利運作。我們是一家大型公司,但我們有很多機會。所以我們希望確保能追蹤進度並按計畫推進。我們已將管理式醫療(managed care)的合約集中化。我們現在有一個資料庫。我們對合約時點、費率有更好的可視性。我們也有一個團隊,確保這些進展能持續。我們也對財務架構與報表做了一些調整,讓我們能更清楚掌握日常成本管理。我認為這裡的團隊非常強。我想這是一個已在這裡好幾年的團隊。他們合作得很好。但我們嘗試做的是,在既有優勢之上再加強,並提升可視性,了解我們能做什麼來加速成長,同時也管理日常成本與績效改善措施。
Operator
Operator
Our next question comes from Ryan Daniels from William Blair.
接下來的問題來自William Blair的Ryan Daniels。
Nicholas Charles Spiekhout - Associate
Nicholas Charles Spiekhout - Associate
This is Nick Spiekhout in for Ryan. First just to clarify, was that walk down from the 700-bed addition target to that 650? Or is that 50 beds you saw on those places that are struggling operationally?
我是代替Ryan的Nick Spiekhout。首先想確認一下,床位新增目標從700張下修到650張,是目標下修嗎?還是那50張床位是你們在那些營運上有困難的據點所看到的?
David M. Duckworth - CFO
David M. Duckworth - CFO
No. Nick, we actually have opened beds at many of those facilities already or will continue with the bed additions that we have at those identified facilities in the fourth quarter. The slight adjustment to our bed additions target for 2019 from 700 to 650 is just one project being delayed to next year. So we will have that project in our numbers next year, but there was a delay from when we expect it to happen.
不是。Nick,我們其實已經在許多那些設施開出床位,或將在第四季持續在那些已識別的設施進行床位新增。我們把2019年床位新增目標從700調整到650,僅僅是因為有一個專案延後到明年。所以明年我們的數字會包含那個專案,只是它發生的時間點比我們原先預期的晚。
Nicholas Charles Spiekhout - Associate
Nicholas Charles Spiekhout - Associate
Got you. Great. And then can you provide a little bit more color in the downtick in same facility U.K. margins? Is that mostly a ForEx issue? Or can you just provide a little more color there?
了解。很好。那你能否就英國同店(same facility)利潤率下滑提供更多說明?那主要是外匯(ForEx)因素嗎?或者你能再多補充一些背景嗎?
David M. Duckworth - CFO
David M. Duckworth - CFO
No. There's -- the FX is adjusted in our reporting of our same facility stats. So that's not the case. I think as you compare the third quarter to the second quarter, we talk about seasonality that we expect to see in the third quarter each year related to mainly the holiday season that occurs in August in the U.K. So sequentially, that's what we saw on the U.K. results, but we're very pleased with the margin -- the comparison to the prior year and stability there in the U.K. But sequentially, in the third quarter of each year, we do expect a slightly lower number than the second quarter.
不是。外匯(FX)已在我們同店設施統計的報告中進行調整。所以不是那樣。我認為,當你比較第三季與第二季時,我們談到每年第三季會出現的季節性,主要與英國在八月的假期季有關。
Nicholas Charles Spiekhout - Associate
Nicholas Charles Spiekhout - Associate
Got you. And then, I guess, I have a quick clarification. I don't know if you've said this before, but the $20 million to $25 million in procurement savings, is there a breakdown of U.S. versus U.K. there? Is that mostly going to be in the U.S. business?
了解。然後,我想我有個快速釐清。我不確定你們之前是否提過,但採購節省的2,000萬到2,500萬美元,能否拆分美國與英國各占多少?那主要會是在美國業務上嗎?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Nick, it's all in the U.S. We do have performance initiatives in the U.K., but that's not included in that number.
Nick,全部都在美國。我們在英國也有績效改善計畫,但不包含在那個數字裡。
Operator
Operator
Our next question comes from Whit Mayo from UBS.
下一個問題來自瑞銀(UBS)的Whit Mayo。
Bryan William Ross - Equity Research Associate of Managed Care
Bryan William Ross - Equity Research Associate of Managed Care
This is Bryan Ross on for Whit. In the U.K., same-store EBITDA growth in the quarter, it looks like it was up 2% and that's inclusive of the rate increase. Is there any way that you can size the revenue dollar impact that, that had in the quarter? Or maybe look at it another way, how did same-store cost per patient day trend in the U.K.?
我是代Whit提問的Bryan Ross。在英國,本季同店EBITDA成長看起來約為2%,且已包含費率上調的影響。你們能否量化一下這對本季營收(以美元金額計)的影響?或者換個角度看,英國同店每病人日成本的趨勢如何?
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. Bryan, we did see an increase in our cost per patient day, but we talk about the acuity of the patients that we're seeing following some of the retooling that has happened and more growth that we have within the higher acuity services. And so what we are focused on is the revenue per day reflecting that higher acuity. And we talked about the revenue per day growth being strong because of the rate increases as well as that higher acuity. And so yes, we did see a cost per patient day increase, but it was in line with the service mix benefit that is reflected in our revenue per day growth.
可以。Bryan,我們確實看到每病人日成本上升,但我們也談到,隨著一些重新調整(retooling)完成,以及我們在更高病情嚴重度(acuity)服務上的成長,所接觸到的病人病情嚴重度有所提高。因此我們關注的是,每日營收能反映這種更高的病情嚴重度。我們也提到,每日營收成長強勁,原因包括費率上調以及更高的病情嚴重度。所以是的,我們看到每病人日成本上升,但這與服務組合帶來的效益一致,而該效益也反映在我們每日營收的成長之中。
Bryan William Ross - Equity Research Associate of Managed Care
Bryan William Ross - Equity Research Associate of Managed Care
Got it. And then quickly, U.S., I know you talked about the de novo before. But on the losses, is there any update on the performance of those in the quarter? I think you had mentioned $1.2 million expected. Just if there's any change there in the actual performance.
了解。接著很快問一下美國部分,我知道你們之前談過新設(de novo)。但就虧損而言,本季這些設施的表現有沒有更新?我記得你們提到預期約120萬美元。想確認實際表現是否有任何變化。
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. Sure, Bryan. We had an expectation for the third quarter of losses between $1 million and $2 million, and we were right in the middle at $1.5 million that is essentially taking half of the losses that we had in the second quarter. So we're seeing great progress there. And we continue to have a goal at those 2 facilities to be at breakeven by the end of the year. So it was close to $3 million for the second quarter, $1.5 million in the third, and we still think those facilities can be breakeven by the end of the year.
有的。當然,Bryan。我們對第三季的虧損預期在100萬到200萬美元之間,而實際是150萬美元,基本上相當於第二季虧損的一半。所以我們看到很大的進展。我們仍以年底前讓那兩家設施達到損益兩平為目標。因此第二季接近300萬美元,第三季150萬美元,我們仍認為這些設施在年底前可以達到損益兩平。
Operator
Operator
We'll now take a follow-up question from Pito Chickering from Deutsche Bank.
接下來我們將接受德意志銀行(Deutsche Bank)的Pito Chickering的追問。
Philip Chickering - Research Analyst
Philip Chickering - Research Analyst
Quick questions for you on the U.K. sale comments. Can you talk a little bit more about the process? Can you give us some -- like early reads on what type of buyers you're talking to, when the first bids are due and then when you think final bids will be due?
關於你們對英國出售的評論,我有幾個快速問題。能否再多談一些流程?你能否給我們一些初步觀察,例如你們正在接觸哪些類型的買家、第一輪出價何時截止,以及你們認為最終出價大概何時截止?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Well, I can say, and I've said before, we have a lot of interested parties that have reached out to us, and we've obviously contacted with our advisers. And I think they vary from infrastructure to private equity and also strategic. And I think that -- I think what has given us optimism here is that the number of interested parties is very strong. And we don't have a view on valuation at this point but we do see that there's interest. And we've done a number of things with our interested parties around informal conversations, which they call fireside chats in the U.K., but it's really trying to educate our potential interested parties about the market and Priory specifically. And I think that those, I think, have moved along. And so as we look at the first part of the year, we have said, and I said in my prepared remarks, that we expect that to start the first part of the year. I think we will have the elections, and there is a holiday period that will occur there as well as here. And so I think that we feel like once we initiate that process, we'll see where we are with respect to how valuation comes in and we'll move from there. So we're not really trying to state a prediction around how long the process goes but we want to make sure we take time to get everyone that has an interest in bidding to bid, and then we'll evaluate those bids. And the next step will be, hopefully, to refine that number and to continue to move forward.
我可以說,而且我之前也說過,我們有很多有興趣的各方主動聯繫我們,我們也已與顧問合作接洽。我認為買方類型涵蓋基礎建設類、私募股權(private equity)以及策略型買家。我想——讓我們感到樂觀的是,有興趣的各方數量非常強勁。目前我們對估值沒有既定看法,但確實看到市場興趣。我們也與有興趣的各方進行了多項非正式交流,在英國他們稱之為「爐邊談話」(fireside chats),但本質上是試圖讓潛在買方更了解市場以及Priory的具體情況。我認為這些交流已經有所推進。因此,當我們看明年上半年時,我們已表示——我在事先準備的發言中也提到——我們預期會在上半年啟動。我想屆時會有選舉,也會有假期期間,英國那邊以及我們這邊都是如此。所以我認為,一旦我們啟動流程,我們會看估值結果如何,再從那裡往下推進。因此我們不太想對流程會持續多久做出預測,但我們希望確保給所有有意出價的各方足夠時間出價,然後我們會評估這些出價。下一步希望能縮小範圍並持續推進。
Operator
Operator
We will now take our next question from John Ransom from Raymond James.
接下來我們將接受Raymond James的John Ransom的提問。
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
Back when you released your strategic plan, you had a view on the U.K. real estate value of $1.7 billion. Do you still have that view? And if so, can you provide any of the detail around what supports that assumption?
當你們發布策略計畫時,你們對英國不動產價值的看法是17億美元。你們現在仍然維持這個看法嗎?如果是,能否提供一些支持該假設的細節?
David M. Duckworth - CFO
David M. Duckworth - CFO
Yes. John, the $1.7 billion that we discussed in May is the real estate value that is on our balance sheet at that point in time. We do not have to share an updated view around the real estate value. It is part of the work that we are doing with our advisers is to evaluate the real estate. We have 80% ownership and significant value in that real estate in the U.K., but we don't have an updated valuation at this point in the process.
是的。John,我們在5月討論的17億美元,是當時點我們資產負債表上所列示的不動產價值。我們不需要分享更新後的不動產價值看法。我們與顧問正在進行的工作之一,就是評估不動產。我們在英國不動產有80%的持有比例,且具有相當的價值,但在目前流程階段我們還沒有更新的估值。
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
Well, maybe I could ask it this way. Is there a comparable cap rate we should think about for especially medical real estate that you've seen in other transactions over there?
那也許我換個方式問。就你們在那邊其他交易中看到的情況,特別是醫療不動產,有沒有一個可比的資本化率(cap rate)是我們應該參考的?
David M. Duckworth - CFO
David M. Duckworth - CFO
We don't have a view that we're going to provide on any valuation metrics within how you might assign a value to the real estate.
我們不會就任何估值指標提供看法,包括你可能用來為不動產賦值的方式。
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
So your valuation was just based on your carrying value on your balance sheet, not what you thought the market would give you for it?
所以你們的估值只是基於資產負債表上的帳面價值,而不是你們認為市場會願意為它支付的價格?
David M. Duckworth - CFO
David M. Duckworth - CFO
That's right, John. That $1.7 billion was based on the appraisal work that we did at the time of acquisition of those various properties starting in 2014 through the Priory acquisition in 2016.
沒錯,John。那 17 億美元是基於我們在 2014 年起收購各項物業、一直到 2016 年 Priory 收購案期間,於收購當時所做的估價工作。
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
So is it possible though that one of the outcomes would be kind of an opco/propco type transaction? Or do you think it's more likely you're just going to sell this thing for a multiple of EBITDA, and the buyer would then extract the value down the road from the real estate?
那麼,有沒有可能其中一種結果會是類似 opco/propco 的交易?還是你認為更可能只是以 EBITDA 倍數把這個業務賣掉,然後買方再在未來從不動產中提取價值?
David M. Duckworth - CFO
David M. Duckworth - CFO
I think our goal is to look at a sale of the entirety of the U.K. operations. If there is a structure like that, that makes sense, it could be something that we could help a buyer execute. But our goal is to sell the entirety of the operations.
我認為我們的目標是尋求出售英國業務營運的整體。如果有那樣的架構且合理,這可能是我們可以協助買方執行的方案。但我們的目標是出售整體營運。
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
John Wilson Ransom - MD of Equity Research & Director of Healthcare Research
Okay. And then I guess my other question is this is the third year in a row, as you know, that you've missed on 3Q. So when you think about your guidance next year, is it possible to maybe factor in a little more cushion for Murphy's law? It's seems like it's -- I don't remember the last time you didn't miss 3Q by a pretty wide margin. So is there a thought to maybe adjusting your guidance to be a bit more -- provide you a little more cushion for that to happen?
好的。然後我想我另一個問題是,如你所知,這已經是你們連續第三年在第三季(3Q)未達預期。所以當你們思考明年的指引時,是否可能把「墨菲定律」的緩衝空間多納入一些?看起來是——我不記得上一次你們沒有在第三季以相當大的幅度失準是什麼時候了。所以是否有考慮把指引調整得更——給你們多一點緩衝,以防這種情況發生?
David M. Duckworth - CFO
David M. Duckworth - CFO
Well, we'll obviously share more about our guidance in February. I think as we reflect back, there's obviously very unique items that have happened in each of the last several years. So we don't think there's any rhyme or reason to it. It's just unfortunate timing on the various issues. But of course, we look forward to providing our 2020 outlook in February.
我們當然會在 2 月分享更多關於指引的內容。我想回顧過去,過去幾年每一年都發生了非常獨特的事項。所以我們不認為這之間有任何規律可循。只是各種問題發生的時點不巧。但當然,我們期待在 2 月提供我們對 2020 年的展望。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
I'll just add, John, that we are going through a budget process right now, and we have asked the operators to give us a view of what they believe next year will look like. We feel like it's -- they're optimistic about what they can do with bed additions and other metrics. I will say that all but 1 of the 5 facilities that we've had to mention because of issues that were unique to them, we're at budget to the second -- to the first half of the year. So -- but we'll be doing a very thorough view of budgets, looking at it by facility, by region, trying to anticipate opportunity but also any challenges that they might face and incorporating both of those views in a budget and then guidance that we'll give on our first quarter call.
我再補充一下,John,我們目前正在進行預算編製流程,我們已要求各營運單位提供他們認為明年會是什麼樣子的看法。我們覺得——他們對於床位增加及其他指標能做到的成果抱持樂觀。我想說的是,在我們因各自獨特問題而必須提到的 5 家機構中,除了 1 家之外,其餘在今年上半年都達到預算。所以——但我們會非常徹底地檢視預算,按機構、按區域來看,嘗試預判機會,也預判他們可能面臨的挑戰,並把這兩種觀點都納入預算,然後在第一季電話會議中提供我們的指引。
Operator
Operator
Our next question comes from Michael Hall from JPMorgan.
下一個問題來自摩根大通(JPMorgan)的 Michael Hall。
Michael Hall;JPMorgan Chase & Co.;Senior Underwriter
Michael Hall;JPMorgan Chase & Co.;Senior Underwriter
I'm on for Gary Taylor. Just a quick follow-up on the U.K. sale, wanted to ask about -- if you have more clarity about why you guys are waiting until after the election in the U.K. holiday period? Any rationale there?
我代替 Gary Taylor 提問。就英國出售案做個簡短追問,想請教——你們是否更清楚為什麼要等到英國選舉之後、以及英國假期期間之後?背後有什麼理由嗎?
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Well, we're taking advice from our advisers who are in the U.K., and I think they have a view that having certainty around those elections is important. And we believe that having certainty there with respect to Parliament will be something that we can move off the table from a buyer perspective. I think that we're going to continue through the end of the year with our discussions with interested parties. So we're not stopping our process. We're just moving the formal initial bid to the first part of the year.
我們是在聽取英國當地顧問的建議,我想他們的看法是,對選舉結果有確定性很重要。我們也相信,對國會組成有確定性,從買方角度來看,會是一個可以排除的不確定因素。我想我們會持續到年底,與有興趣的各方進行討論。所以我們並沒有停止流程。我們只是把正式的初始投標移到明年年初。
Operator
Operator
It appears there are no further questions at this time. So I'd like to turn the conference back to Deborah Osteen for any additional or closing remarks.
看起來目前沒有其他問題。因此我想把電話會議交回給 Deborah Osteen,請她做任何補充或結語。
Debra K. Osteen - CEO & Director
Debra K. Osteen - CEO & Director
Thanks again for being with us today and for your interest in Acadia Healthcare. I would like to conclude by thanking all of our employees and clinicians for their dedication, their focus on providing the highest quality care to our patients and their families.
再次感謝各位今天與會,並感謝各位對 Acadia Healthcare 的關注。最後,我要感謝我們所有員工與臨床人員的投入與奉獻,他們專注於為我們的病患及其家屬提供最高品質的照護。
If you have additional questions today, please do not hesitate to contact us directly, and have a good day.
如果各位今天還有其他問題,請隨時直接與我們聯繫,祝各位有美好的一天。
Operator
Operator
This concludes today's call. Thank you for your participation. You may now disconnect.
今天的電話會議到此結束。感謝各位的參與。各位現在可以掛線。